在健康的一般人口中,功能下降的性别差异
Vetle Saastad1, Ludvig Balteskard Rinde2,3, Inger Therese Enoksen4
1Metabolic and Renal Research Group, UiT Arctic University of Norway, Tromsø, Norway, vsa035@uit.no.
Nephron
|November 18, 2025
概括
与年龄有关的功能下降的性别差异尚不清楚,这可能解释了为什么慢性病 (CKD) 在女性中更常见. 需要进一步的研究来了解这些男性和女性的功能趋势.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 老年学是一门学科.
- 流行病学 流行病学
背景情况:
- 慢性病 (CKD) 在患病率上显示出显著的性别和性别差异,女性3期CKD更常见.
- 这种流行病学悖论的原因,特别是与年龄相关的膜过率 (GFR) 的下降,仍然不完全理解.
- 关于GFR下降的性别差异现有研究是有限的,通常依赖于使用肌素或囊素C的估计GFR (eGFR).
研究的目的:
- 审查现有的关于男性和女性与年龄相关的GFR下降的文献.
- 探索GFR轨迹的潜在基于性别的差异及其对CKD流行差异的贡献.
- 确定影响GFR下降的因素,并突出现有知识的差距.
主要方法:
- 对调查一般人群中与年龄相关的GFR下降的研究进行系统审查.
- 分析用于评估GFR的方法,包括测量GFR和各种eGFR方程.
- 检查研究人口特征,重点关注并发症和风险因素.
主要成果:
- 关于GFR下降的性别差异的发现在研究中是相互矛盾和不一致的.
- 研究群体的变化 (例如,并发症) 和GFR评估方法可能会导致结果矛盾.
- 当前的eGFR方程可能不准确地反映性别特定的GFR下降模式.
结论:
- 在GFR水平和下降率中的性别和性别差异可能在观察到的CKD流行率差异中发挥作用.
- 潜在的促成因素包括生物因素 (例如,性激素),GFR评估方法和不同的风险因素概况.
- 进一步的研究对于阐明特定于性别的GFR下降轨迹及其对CKD的临床影响至关重要.
相关概念视频
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
223
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
223
01:24Serum Studies: Renal Function Tests
345
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
345
01:17Factors Affecting Renal Clearance: Renal Impairment
403
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
403
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
175
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
175
01:25Chronic Kidney Disease I: Introduction
549
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
549
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
198
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
198